Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aranesp vs rHuEPO for Anemia in African-American CRF Patients
NCT00111995Phase 4Completed
- Sponsor
- Amgen
- Start
- May 2002
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
Phase 4, randomised, double-blind trial of darbepoetin alfa in anemia (2 arms), sponsored by Amgen. Primary endpoint: Mean hemoglobin level during the evaluation period. Started May 2002; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00111995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00111995.